Biocartis Group Return On Equity vs. Price To Book
| BCART Stock | EUR 0.29 0.00 0.00% |
For Biocartis Group profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biocartis Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biocartis Group NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biocartis Group's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biocartis Group NV over time as well as its relative position and ranking within its peers.
Biocartis |
Biocartis Group NV Price To Book vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biocartis Group's current stock value. Our valuation model uses many indicators to compare Biocartis Group value to that of its competitors to determine the firm's financial worth. Biocartis Group NV is number one stock in return on equity category among its peers. It also is number one stock in price to book category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biocartis Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biocartis Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biocartis Price To Book vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Biocartis Group |
| = | -48.84 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Biocartis Group |
| = | 6.47 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Biocartis Price To Book Comparison
Biocartis Group is currently under evaluation in price to book category among its peers.
Biocartis Group Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biocartis Group, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biocartis Group will eventually generate negative long term returns. The profitability progress is the general direction of Biocartis Group's change in net profit over the period of time. It can combine multiple indicators of Biocartis Group, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people.
Biocartis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biocartis Group. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biocartis Group position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biocartis Group's important profitability drivers and their relationship over time.
Use Biocartis Group in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocartis Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will appreciate offsetting losses from the drop in the long position's value.Biocartis Group Pair Trading
Biocartis Group NV Pair Trading Analysis
The ability to find closely correlated positions to Biocartis Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocartis Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocartis Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocartis Group NV to buy it.
The correlation of Biocartis Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocartis Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocartis Group NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocartis Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biocartis Group position
In addition to having Biocartis Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Cap ETFs Thematic Idea Now
Small Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small Cap ETFs theme has 167 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biocartis Stock
To fully project Biocartis Group's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biocartis Group NV at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biocartis Group's income statement, its balance sheet, and the statement of cash flows.